New hair serum could be a Game-Changer for thinning hair
NCT ID NCT06556056
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This study tested a new hair growth serum called SesZen-Bio in 108 people with mild to moderate androgenic alopecia (baldness). Participants used the serum daily on their scalp, and researchers measured changes in hair thickness, density, and growth rate compared to a standard treatment (minoxidil) and a placebo. The goal was to see if the serum is safe and effective for treating hair loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NovoBliss Research Private Limited
Ahmedabad, Gujarat, 382481, India
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SesZen-Bio Serum
What this could lead to
If it works, this could offer a new option for treating hair loss without needing lifelong medication.
What could go wrong
This is a small, early-stage trial with no phase, so results may not be conclusive. The serum may not work better than existing treatments or placebo.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.